Cargando…
Secondary pulmonary alveolar proteinosis treated by lung transplant: A case report
Background. Pulmonary alveolar proteinosis (PAP) is a pulmonary disease characterized by disruption of surfactant homeostasis resulting in its accumulation in the alveoli. PAP is classically classified into three categories (Table 1): 1/primary (or autoimmune) with antibodies targeting the GM-CSF pa...
Autores principales: | Lawi, David, Dubruc, Estelle, Gonzalez, Michel, Aubert, John-David, Soccal, Paola M., Janssens, Jean-Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276430/ https://www.ncbi.nlm.nih.gov/pubmed/32528843 http://dx.doi.org/10.1016/j.rmcr.2020.101108 |
Ejemplares similares
-
Lung Transplant Recipient with Pulmonary Alveolar Proteinosis
por: Tokman, Sofya, et al.
Publicado: (2016) -
Pulmonary alveolar proteinosis after lung transplantation
por: Divithotawela, Chandima, et al.
Publicado: (2020) -
Sirolimus-induced secondary pulmonary alveolar proteinosis
por: Wang, Stephanie, et al.
Publicado: (2021) -
Whole lung lavage for pulmonary alveolar proteinosis
por: Jayaraman, S., et al.
Publicado: (2010) -
Whole lung lavage: Treating pulmonary alveolar proteinosis at the time of COVID pandemic()
por: Powers, Katherine Jean, et al.
Publicado: (2022)